Effect of NRG-1/ErbB signaling intervention on the differentiation of bone marrow stromal cells into sinus node-like cells

Journal of Cardiovascular Pharmacology

Volumn 63, Issue 5, 2014, Pages 434-440

  Li, Yong ^a   Li, Bingong ^a   Zhang, Changlie ^b   Zhang, Jian ^a   Zeng, Minghui ^a   Zheng, Zeqi ^a  

^a NANCHANG UNIVERSITY   (China)

^b LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

Bone marrow stromal cells; NRG 1; Sinus nodelike cells

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; AZACITIDINE; EPIDERMAL GROWTH FACTOR RECEPTOR; FIBROBLAST GROWTH FACTOR 2; NEU DIFFERENTIATION FACTOR; PROTEIN; PROTEIN HCN4; PROTEIN KINASE B; PROTEIN TBX2; PROTEIN TBX3; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; QUINAZOLINE DERIVATIVE; TYRPHOSTIN;

ACTION POTENTIAL; ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COCULTURE; CONTROLLED STUDY; GENE; GENE EXPRESSION; HCN4 GENE; HEART MUSCLE CELL; MOLECULAR BIOLOGY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINUS NODE; STROMA CELL; TBX2 GENE; TBX3 GENE; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

ACTION POTENTIALS; ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; ERBB RECEPTORS; NEUREGULIN-1; QUINAZOLINES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SINOATRIAL NODE; STROMAL CELLS; TYRPHOSTINS;

EID: 84900847410     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000068     Document Type: Article

References (38)

1. He JQ, Ma Y, Lee Y, et al Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ Res. 2003;93:32-39.
2. Moore JC, Fu J, Chan YC, et al. Distinct cardiogenic preferences of two human embryonic stem cell (hESC) lines are imprinted in their proteomes in the pluripotent state. Biochem Biophys Res Commun. 2008; 372:553-558.
3. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697-705.
4. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284:143-147.
5. Meligy FY, Shigemura K, Behnsawy HM, et al. The efficiency of in vitro isolation and myogenic differentiation of MSCs derived from adipose connective tissue, bone marrow, and skeletal muscle tissue. In Vitro Cell Dev Biol Anim. 2012;48:203-215.
6. Yoon J, Shim WJ, Ro YM, et al. Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Ann Hematol. 2005;84: 715-721.
7. Wang T, Xu Z, Jiang W, et al. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int J Cardiol. 2006;109:74-81.
8. Garbade J, Schubert A, Rastan AJ, et al. Fusion of bone marrow-derived stem cells with cardiomyocytes in a heterologous in vitro model. Eur J Cardiothorac Surg. 2005;28:685-691.
9. Pentassuglia L, Sawyer DB. The role of Neuregulin-1beta/ErbB signaling in the heart. Exp Cell Res. 2009;315:627-637.
10. Odiete O, Hill MF, Sawyer DB. Neuregulin in cardiovascular development and disease. Circ Res. 2012;111:1376-1385.
11. Lemmens K, Doggen K, De Keulenaer GW. Role of neuregulin-1/ErbB signaling in cardiovascular physiology and disease: implications for therapy of heart failure. Circulation. 2007;116:954-960.
12. Zhu WZ, Xie Y, Moyes KW, et al. Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells. Circ Res. 2010;107:776-786.
13. Zhang J, Chatterjee K, Alano CC, et al. Vincristine attenuates N-methyl- N'-nitro-N- nitrosoguanidine-induced poly-(ADP) ribose polymerase activity in cardiomyocytes. J Cardiovasc Pharmacol. 2010;55:219-226.
14. Sayed D, Rane S, Lypowy J, et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell. 2008;19:3272-3282.
15. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315-317.
16. Christoffels VM, Burch JB, Moorman AF. Architectural plan for the heart: early patterning and delineation of the chambers and the nodes. Trends Cardiovasc Med. 2004;14:301-307.
17. Evans SM, Yelon D, Conlon FL, et al. Myocardial lineage development. Circ Res. 2010;107:1428-1444.
18. Wiese C, Grieskamp T, Airik R, et al. Formation of the sinus node head and differentiation of sinus node myocardium are independently regulated by Tbx18 and Tbx3. Circ Res. 2009;104:388-397.
19. Jensen B, Boukens BJ, Postma AV, et al. Identifying the evolutionary building blocks of the cardiac conduction system. PLoS One. 2012;7: e44231.
20. Hoogaars WM, Engel A, Brons JF, et al. Tbx3 controls the sinoatrial node gene program and imposes pacemaker function on the atria. Genes Dev. 2007;21:1098-1112.
21. McNally EM, Svensson EC. Setting the pace: Tbx3 and Tbx18 in cardiac conduction system development. Circ Res. 2009;104:285-287.
22. Singh R, Hoogaars WM, Barnett P, et al. Tbx2 and Tbx3 induce atrioventricular myocardial development and endocardial cushion formation. Cell Mol Life Sci. 2012;69:1377-1389.
23. DiFrancesco D. The role of the funny current in pacemaker activity. Circ Res. 2010;106:434-446.
24. Mommersteeg MT, Hoogaars WM, Prall OW, et al. Molecular pathway for the localized formation of the sinoatrial node. Circ Res. 2007;100: 354-362.
25. Espinoza-Lewis RA, Liu H, Sun C, et al. Ectopic expression of Nkx2.5 suppresses the formation of the sinoatrial node in mice. Dev Biol. 2011; 356:359-369.
26. Yarden Y, Sliwkowski MX. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2:127-137.
27. Meyer D, Birchmeier C. Multiple essential functions of neuregulin in development. Nature. 1995;378:386-390.
28. Hedhli N, Huang Q, Kalinowski A, et al. Endothelium-derived neuregulin protects the heart against ischemic injury. Circulation. 2011;123: 2254-2262.
29. Wang XH, Zhuo XZ, Ni YJ, et al. Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1beta in volume-overloaded rats with heart failure. J Geriatr Cardiol. 2012; 9:172-179.
30. Liu X, Gu X, Li Z, et al. Neuregulin-1/ErbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy. J Am Coll Cardiol. 2006;48:1438-1447.
31. Li B, Zheng Z, Wei Y, et al. Therapeutic effects of neuregulin-1 in diabetic cardiomyopathy rats. Cardiovasc Diabetol. 2011;10:69.
32. Xiao J, Li B, Zheng Z, et al. Therapeutic effects of neuregulin-1 gene transduction in rats with myocardial infarction. Coron Artery Dis. 2012; 23:460-468.
33. Lai D, Liu X, Forrai A, et al. Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. Circ Res. 2010;107:715-727.
34. Bersell K, Arab S, Haring B, et al. Neuregulin1/ErbB4 signaling induces cardiomyocyte proliferation and repair of heart injury. Cell. 2009;138: 257-270.
35. Wang Z, Xu G, Wu Y, et al. Neuregulin-1 enhances differentiation of cardiomyocytes from embryonic stem cells. Med Biol Eng Comput. 2009;47:41-48.
36. Qiu FY, Song XX, Zheng H, et al. Thymosin beta4 induces endothelial progenitor cell migration via PI3K/Akt/eNOS signal transduction pathway. J of Cardiovasc Pharmacol. 2009;53:209-214.
37. Rose RA, Kabir MG, Backx PH. Altered heart rate and sinoatrial node function in mice lacking the cAMP regulator phosphoinositide 3-kinasegamma. Circ Res. 2007;101:1274-1282.
38. Alloatti G, Marcantoni A, Levi R, et al. Phosphoinositide 3-kinase gamma controls autonomic regulation of the mouse heart through Gi-independent downregulation of cAMP level. FEBS Lett. 2005;579: 133-140.